CIK 0001720893
- Non-accelerated filer
- Smaller reporting company
BioXcel Therapeutics, Inc.
Sign in to watch- Ticker
- BTAIQ
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 821386754
- Phone
- +1 203-643-8060
- Business address
- 555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
- 4 Exercise or conversion Chief Scientific Officer acquired 521 shares (option exercise)
- 4 Exercise or conversion Chief Financial Officer acquired 521 shares (option exercise)
- 4 Exercise or conversion Rodriguez Javier acquired 521 shares (option exercise)
- 4 Exercise or conversion Chief Medical Officer acquired 521 shares (option exercise)
- 4 Exercise or conversion CEO and President acquired 2,610 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Rodriguez Javier acquired 521 shares (option exercise)
- 4 Exercise or conversion Chief Scientific Officer acquired 521 shares (option exercise)
- 4 Exercise or conversion Chief Financial Officer acquired 521 shares (option exercise)
- 4 Planned sale CEO and President sold 60,000 shares at an average $20.86 ($1,251,727)
- 4 Exercise or conversion Chief Medical Officer acquired 521 shares (option exercise)
- 4 Planned sale CEO and President sold 6,500 shares at $25.79 ($167,641)
- 4 Exercise or conversion CEO and President acquired 15,000 shares (option exercise)
- 4 Planned sale Chief Financial Officer sold 5,000 shares at $27.17 ($135,864)
- 4 Planned sale Rodriguez Javier sold 1,785 shares at $27.32 ($48,765)
- 3 Insider Initial Statement of Ownership
Page 7 of 14 · 276 filings